Lannett Company, Inc.  

(Public, NYSE:LCI)   Watch this stock  
Find more results for Cody Smith
66.16
-1.24 (-1.84%)
Real-time:   11:41AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 66.10 - 68.59
52 week 31.90 - 72.44
Open 67.52
Vol / Avg. 331,731.00/866,131.00
Mkt cap 2.37B
P/E 19.38
Div/yield     -
EPS 3.41
Shares 35.80M
Beta 1.47
Inst. own 57%
May 5, 2015
Q3 2015 Lannett Company Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Apr 14, 2015
Lannett Company Inc at Needham Healthcare Conference
Mar 9, 2015
Lannett Company Inc at ROTH Conference
Feb 24, 2015
Lannett Company Inc at RBC Healthcare Conference
Feb 11, 2015
Lannett Company Inc at Leerink Global Healthcare Conference
Feb 4, 2015
Q2 2015 Lannett Company Inc Earnings Call
Feb 4, 2015
Q2 2015 Lannett Company Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 39.04% 20.88%
Operating margin 57.95% 32.18%
EBITD margin - 34.37%
Return on average assets 45.07% 22.39%
Return on average equity 50.51% 27.00%
Employees 399 -
CDP Score - -

Address

9000 State Rd
PHILADELPHIA, PA 19136-1615
United States - Map
+1-215-3339000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Lannett Company, Inc. develops, manufactures, packages, markets and distributes solid oral (tablets and capsules), extended release, topical and oral solution finished dosage forms of drugs. The Company also manufactures active pharmaceutical ingredients through its Cody Laboratories, Inc. (Cody Labs) subsidiary. The Company operates pharmaceutical manufacturing plants in Philadelphia, Pennsylvania and Cody, Wyoming. Customers of the Company�s pharmaceutical products include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, Governmental entities and health maintenance organizations. The Company�s products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital, Cocaine Topical Solution and Morphine Sulfate Oral Solution.

Officers and directors

Jeffrey Farber Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
Michael J. Bogda President
Age: 53
Bio & Compensation  - Reuters
Arthur P. Bedrosian J.D. Chief Executive Officer, Director
Age: 69
Bio & Compensation  - Reuters
Martin P. Galvan CPA, Chief Financial Officer, Vice President - Finance, Treasurer
Age: 62
Bio & Compensation  - Reuters
William F. Schreck Chief Operating Officer
Age: 66
Bio & Compensation  - Reuters
Robert Ehlinger Vice President - Logistics, Chief Information Officer
Age: 57
Bio & Compensation  - Reuters
Kevin R. Smith Vice President - Sales and Marketing
Age: 54
Bio & Compensation  - Reuters
William R. Farber Ph.D. Chairman Emeritus
Age: 83
Bio & Compensation  - Reuters
David Drabik Independent Director
Age: 46
Bio & Compensation  - Reuters
James M. Maher Independent Director
Age: 62
Bio & Compensation  - Reuters